Search Browse Earnings

CHIMERIX INC

Pharmaceutical Preparations·DURHAM, NC

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CHIMERIX INC — SlamSEC

Revenue

$33.8M

+1609.1% YoY

FY 2024

Adj. EBITDA

-$60.3M

-178.2% margin

FY 2024

Net Income

$172.2M

509.0% margin

FY 2024

EPS (Diluted)

$1.94

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$47.0M

FY 2021

Total Debt

$14.0M

FY 2022

Net Cash

$33.0M

FY 2022

Enterprise Value

—

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

—

Employees

—